Cargando…

Final results of the DisCoVeRy trial of remdesivir for patients admitted to hospital with COVID-19

Detalles Bibliográficos
Autores principales:	Ader, Florence, Bouscambert-Duchamp, Maude, Hites, Maya, Peiffer-Smadja, Nathan, Mentré, France, Burdet, Charles
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2022
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9132543/ https://www.ncbi.nlm.nih.gov/pubmed/35643099 http://dx.doi.org/10.1016/S1473-3099(22)00295-X

Ejemplares similares

Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial
por: Ader, Florence, et al.
Publicado: (2022)

Remdesivir, on the road to DisCoVeRy
por: Gyselinck, Iwein, et al.
Publicado: (2022)

Management of pharmacovigilance during the COVID‐19 pandemic crisis by the safety department of an academic sponsor: Lessons learnt and challenges from the EU DisCoVeRy clinical trial
por: Mercier, Noémie, et al.
Publicado: (2023)

Ensuring quality control in a COVID-19 clinical trial during the pandemic: The experience of the Inserm C20–15 DisCoVeRy study
por: Fougerou-Leurent, Claire, et al.
Publicado: (2023)

Protocol for the DisCoVeRy trial: multicentre, adaptive, randomised trial of the safety and efficacy of treatments for COVID-19 in hospitalised adults
por: Ader, Florence
Publicado: (2020)

Accelerating clinical trial implementation in the context of the COVID-19 pandemic: challenges, lessons learned and recommendations from DisCoVeRy and the EU-SolidAct EU response group
por: Diallo, Alpha, et al.
Publicado: (2022)

COVID-19: Failure of the DisCoVeRy Clinical Trial, and Now–New Hopes?
por: Vanden Eynde, Jean Jacques
Publicado: (2021)

Assessing the evidence on remdesivir
por: Trøseid, Marius, et al.
Publicado: (2021)

Effects of remdesivir in patients hospitalised with COVID-19: a systematic review and individual patient data meta-analysis of randomised controlled trials
por: Amstutz, Alain, et al.
Publicado: (2023)

Efficacy of Oseltamivir-Zanamivir Combination Compared to Each Monotherapy for Seasonal Influenza: A Randomized Placebo-Controlled Trial
por: Duval, Xavier, et al.
Publicado: (2010)

Correction: Efficacy of Oseltamivir-Zanamivir Combination Compared to Each Monotherapy for Seasonal Influenza: A Randomized Placebo-Controlled Trial
por: Duval, Xavier, et al.
Publicado: (2010)

Performance of Self-Collected Saliva Testing Compared with Nasopharyngeal Swab Testing for the Detection of SARS-CoV-2
por: Carrouel, Florence, et al.
Publicado: (2021)

Assurer le contrôle qualité d'un essai clinique pendant la pandémie de COVID-19 : l'expérience de l'étude Inserm C20-15 DisCoVeRy en France
por: Fougerou-leurent, C., et al.
Publicado: (2022)

Hadronic final states in DIS with Sherpa
por: Carli, Tancredi, et al.
Publicado: (2010)

Type 1 interferons as a potential treatment against COVID-19
por: Sallard, Erwan, et al.
Publicado: (2020)

Real-world effectiveness of oral antivirals for COVID-19
por: Burdet, Charles, et al.
Publicado: (2022)

Hadron distributions in the final state of DIS at HERA
por: Anisovich, A V, et al.
Publicado: (1993)

La négativité persistante des prélèvements nasopharyngés est-elle fiable pour éliminer une pneumonie au SARS-CoV-2 chez un patient en quarantaine post-exposition ?
por: Benech, N., et al.
Publicado: (2020)

Rapid and reliable inactivation protocols for the diagnostics of emerging viruses: The example of SARS‐CoV‐2 and monkeypox virus
por: Quéromès, Grégory, et al.
Publicado: (2022)

Remdesivir for the Treatment of Covid-19 — Final Report
por: Beigel, John H., et al.
Publicado: (2020)

An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19
por: Ader, Florence, et al.
Publicado: (2021)

The NS Segment of H1N1pdm09 Enhances H5N1 Pathogenicity in a Mouse Model of Influenza Virus Infections
por: Ferraris, Olivier, et al.
Publicado: (2018)

Use of an antiviral mouthwash as a barrier measure in the SARS-CoV-2 transmission in adults with asymptomatic to mild COVID-19: a multicentre, randomized, double-blind controlled trial
por: Carrouel, Florence, et al.
Publicado: (2021)

Vaccination on E. I. Ry.
por: Waters, H. G.
Publicado: (1917)

An open-label randomized, controlled trial of the effect of lopinavir and ritonavir, lopinavir and ritonavir plus interferon-β-1a, and hydroxychloroquine in hospitalized patients with COVID-19: final results
por: Ader, Florence
Publicado: (2022)

Joint modeling under competing risks: Application to survival prediction in patients admitted in Intensive Care Unit for sepsis with daily Sequential Organ Failure Assessment score assessments
por: Lavalley‐Morelle, Alexandra, et al.
Publicado: (2022)

“You don’t want to lose that trust that you’ve built with this patient…”: (Dis)trust, medical tourism, and the Canadian family physician-patient relationship
por: Crooks, Valorie A, et al.
Publicado: (2015)

They've said it, they've done it
por: Association
Publicado: (2007)

Synergistic FRET assays for drug discovery targeting RyR2 channels
por: Rebbeck, RobynT., et al.
Publicado: (2022)

Shared graft-versus-leukemia minor histocompatibility antigens in DISCOVeRY-BMT
por: Olsen, Kelly S., et al.
Publicado: (2022)

Progress and Problems in QCD: Report from the Hadronic Final States Working Group at DIS '99
por: Cacciari, Matteo, et al.
Publicado: (1999)

Placental lesions and SARS-Cov-2 infection: Diffuse placenta damage associated to poor fetal outcome
por: Bouachba, Amine, et al.
Publicado: (2021)

Bamlanivimab as monotherapy in two immunocompromised patients with COVID-19
por: Destras, Grégory, et al.
Publicado: (2021)

Kabelek, kt ry wstrzymał boską maszynę
Publicado: (2009)

Structure of RyR1 in native membranes
por: Chen, Wenbo, et al.
Publicado: (2020)

On the Elimination of Morphine Ry the Milk of the Nursing Woman
Publicado: (1890)

¡Ve ese! /
por: Grañén Porrúa, Ma. Isabel (María Isabel)
Publicado: (2007)

Identification of RyR2-PBmice and the effects of transposon insertional mutagenesis of the RyR2 gene on cardiac function in mice
por: Wang, Qianqian, et al.
Publicado: (2019)

CPT: Pharmacometrics & Systems Pharmacology 2.0
por: Mentré, France
Publicado: (2019)

Evaluating the Clinical Outcomes of Remdesivir Among Patients Admitted With COVID-19 in a Tertiary Care Hospital
por: Butt, Ahmad G, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_n240qonlbfho7ka96jb7dgh1aq